Company intelligence / Profile preview

Nuwacell Biotechnologies

Hefei(main HQ/R&D location), Anhui Sheng(Anhui Province), 中国(China)en.nuwacell.com ↗
Ownership
Private
Development stage
Phase 1
01

Overview

Nuwacell has advanced several off-the-shelf, iPSC-derived cell therapy candidates into early-stage clinical trials. Their lead programs include iMSC for knee osteoarthritis in Phase II, genetically modified iMSC for interstitial lung disease in Phase I/II, and iNK-based immunotherapies for hematological malignancies also in Phase I/II. The company is among the first in China to receive IND approval for both iMSC and iNK therapies derived from hiPSCs. No published pivotal efficacy results yet.

Therapeutic areas
PulmonologyOncologyImmunologyHematologyRheumatology
Modalities
Induced pluripotent stem cells (iPSC)iPSC-derived mesenchymal stromal cells (iMSC)iPSC-derived natural killer cells (iNK)Genetically modified cell therapiesBiological products
Industry
Biotech
02

Drug pipeline

7 assets

NCR101

2

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Nuwacell Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuwacell Biotechnologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call